Neonc Technologies and Abu Dhabi health department sign MoU to advance brain cancer research
NTHI•Neonc Technologies and Abu Dhabi’s Department of Health signed an MoU to advance brain cancer research and explore a clinical collaboration. Two children in Abu Dhabi are receiving investigational NEO100, a third is expected this week, and the parties are working to open a Phase 1 study.
1. Clinical collaboration plans
Neonc Technologies Holdings and the Department of Health – Abu Dhabi signed an MoU to advance brain cancer research and proposed clinical collaboration. Two children in Abu Dhabi are receiving investigational NEO100, and a third is expected this week.
2. Phase 1 study
The parties are working to open a Phase 1 study of NEO100 in Abu Dhabi. They will also explore a regional presence and potential manufacturing, supply or distribution by Neonc in Abu Dhabi.
